Delgocitinib is a topical pan-Janus kinase (JAK) inhibitor used in the treatment of moderate to severe chronic hand eczema. This category encompasses essential reference standards, including process-related… Read more

![Chemical structure of 3-((3R,4R)-3-Methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl)-3-oxopropanenitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-3R4R-3-Methyl-6-7H-pyrrolo23-dpyrimidin-4-yl-16-diazaspiro3.4octan-1-yl-3-oxopropanenitrile.png&w=3840&q=75)
![Chemical structure of 3-((3S,4R)-3-Methyl-1,6-diazaspiro[3.4]octan-1-yl)-3-oxopropanenitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2484764-73-8-3-3S4R-3-Methyl-16-diazaspiro3.4octan-1-yl-3-oxopropanenitrile.png&w=3840&q=75)
![Chemical structure of 3-((3S,4R)-6-(7-(2-(4-Isobutylphenyl)propanoyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3-methyl-1,6-diazaspiro[3.4]octan-1-yl)-3-oxopropanenitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2893772-99-9-3-3S4R-6-7-2-4-Isobutylphenylpropanoyl-7H-pyrrolo23-dpyrimidin-4-yl-3-methyl-16-diazaspiro3.4octan-1-yl-3-oxopropanenitrile.png&w=3840&q=75)
![Chemical structure of 3-((3S,4S)-3-Methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl)-3-oxopropanenitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-3S4S-3-Methyl-6-7H-pyrrolo23-dpyrimidin-4-yl-16-diazaspiro3.4octan-1-yl-3-oxopropanenitrile.png&w=3840&q=75)
![Chemical structure of 4-((3S,4R)-1-Benzyl-3-methyl-1,6-diazaspiro[3.4]octan-6-yl)-7H-pyrrolo[2,3-d]pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2230683-35-7-4-3S4R-1-Benzyl-3-methyl-16-diazaspiro3.4octan-6-yl-7H-pyrrolo23-dpyrimidine.png&w=3840&q=75)
![Chemical structure of 4-((3S,4R)-3-Methyl-1,6-diazaspiro[3.4]octan-6-yl)-7H-pyrrolo[2,3-d]pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2064338-19-6-4-3S4R-3-Methyl-16-diazaspiro3.4octan-6-yl-7H-pyrrolo23-dpyrimidine.png&w=3840&q=75)


![Chemical structure of N-(2-Bromoethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2489402-58-4-N-2-Bromoethyl-7H-pyrrolo23-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of tert-Butyl (2R,3S)-2-(2-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)ethyl)-1-(2-cyanoacetyl)-3-methylazetidine-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2489402-59-5-tert-Butyl-2R3S-2-2-7H-pyrrolo23-dpyrimidin-4-ylaminoethyl-1-2-cyanoacetyl-3-methylazetidine-2-carboxylate.png&w=3840&q=75)

Delgocitinib is a topical pan-Janus kinase (JAK) inhibitor used in the treatment of moderate to severe chronic hand eczema. This category encompasses essential reference standards, including process-related impurities, degradation products, and stable isotope labelled compounds specifically designed for analytical testing. Pharmaceutical laboratories rely on these materials for comprehensive impurity profiling, method development, and rigorous quality control. By utilizing characterized reference compounds, analysts can accurately identify, quantify, and monitor the chemical profile of drug substances throughout the research and manufacturing lifecycle. These materials are critical for ensuring regulatory compliance and verifying the accuracy of analytical methods during the structural characterization and stability testing of pharmaceutical products, supporting the development of safe and effective therapeutic treatments.